| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/03/2001 | WO2001030804A2 Salt form of a conjugate useful in the treatment of prostate cancer |
| 05/03/2001 | WO2001030789A1 Ruthenium (ii) complexes with high antitumoral and antimetastatic activities |
| 05/03/2001 | WO2001030754A2 Micro-cluster liquids and methods of making and using them |
| 05/03/2001 | WO2001030448A1 Method and compositions for administering taxanes orally to human patients |
| 05/03/2001 | WO2001030408A2 Adhesive composition over a bioactive polymerization initiator |
| 05/03/2001 | WO2001030397A2 Ultrasound inducement of artial and ventricular rhythms |
| 05/03/2001 | WO2001030393A2 Methods for reducing the effects of cancers that express a33 antigen using a33 antigen specific immunoglobulin products |
| 05/03/2001 | WO2001030392A2 Delivery of proteins across polar epithelial cell layers |
| 05/03/2001 | WO2001030391A2 Pharmaceutical composition containing midazolam |
| 05/03/2001 | WO2001030390A2 Method |
| 05/03/2001 | WO2001030375A2 Use of gdnf for treating corneal defects |
| 05/03/2001 | WO2001030362A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 05/03/2001 | WO2001030351A1 Oral formulations for anti-tumor compounds |
| 05/03/2001 | WO2001030349A1 Amorphous paroxetine compositon |
| 05/03/2001 | WO2001030345A1 Clonidine preparations |
| 05/03/2001 | WO2001030336A2 Pharmaceutical formulations comprising resveratrol and use thereof |
| 05/03/2001 | WO2001030323A2 Controlled-release biocompatible ocular drug delivery implant devices and methods |
| 05/03/2001 | WO2001030319A1 New and improved formulation for paclitaxel |
| 05/03/2001 | WO2001030318A1 Oral solution containing galanthamine and a sweetening agent |
| 05/03/2001 | WO2001030288A1 Oral transmucosal drug dosage using solid solution |
| 05/03/2001 | WO2001030146A1 Encapsulated active material immobilized in hydrogel microbeads |
| 05/03/2001 | WO2001030145A1 Active material within hydrogel microbeads |
| 05/03/2001 | WO2001013893A3 Use of simple amino acids to form porous particles |
| 05/03/2001 | WO2001005968A9 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 05/03/2001 | WO2001003917A3 Multilayered film containing an active substance and made of cross-linked hydrophilic polymers |
| 05/03/2001 | WO2001001139A3 Incorporation and appliations of biomolecular interactions within a carrier |
| 05/03/2001 | WO2000074712A3 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 05/03/2001 | WO2000072876A3 Prevention and treatment of amyloidogenic disease |
| 05/03/2001 | WO2000071165A3 Use of chimeric mutational vectors to change endogenous sequences in solid tissues |
| 05/03/2001 | WO2000056774A8 Methods of using bioelastomers |
| 05/03/2001 | WO2000004875A3 Preparation of aqueous clear solution dosage forms with bile acids |
| 05/03/2001 | WO1999059544A3 Orally disintegrable tablets |
| 05/03/2001 | US20010000785 Attaching a bioeffecting agent to a substrate with an anchor provided by a linker compound which also forms a cleavable linkage so that the drug has a sustained release; anti-thrombogenic, -imicrobial, -inflammatory agents |
| 05/03/2001 | US20010000784 Administering a diester of an N- or N,N'-mono- or diacyl or peptidyl residue of cystine; a food, nutrient or infusion; patient in a cachectic condition; antitumor, -carcinogenic -diabetes agents; gastrointestinal inflammatory diseases |
| 05/03/2001 | DE19949202A1 Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure Transdermal therapeutic system for the delivery of acetylsalicylic acid and / or salicylic acid |
| 05/03/2001 | DE10038203A1 Implantable active agent depot, useful e.g. in local tumor treatment or gene therapy, comprising drug-containing, cubic phase forming lipid matrix containing modifier molecule to control release kinetics |
| 05/03/2001 | CA2389583A1 Method and compositions for administering taxanes orally to human patients |
| 05/03/2001 | CA2389171A1 Ruthenium (ii) complexes with high antitumoral and antimetastatic activities |
| 05/03/2001 | CA2388995A1 Method |
| 05/03/2001 | CA2388934A1 Micro-cluster liquids and methods of making and using them |
| 05/03/2001 | CA2388924A1 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 05/03/2001 | CA2388613A1 New and improved formulation for paclitaxel |
| 05/03/2001 | CA2388611A1 Transdermal drug delivery devices |
| 05/03/2001 | CA2388203A1 Microbe, microbial exopolysaccharide, and uses thereof |
| 05/03/2001 | CA2388165A1 Disulfide conjugated cell toxins and methods of making and using them |
| 05/03/2001 | CA2387907A1 Serum amyloid a isoform from colostrum |
| 05/03/2001 | CA2387901A1 Salt form of a conjugate useful in the treatment of prostate cancer |
| 05/03/2001 | CA2387648A1 Oral formulations for anti-tumor compounds |
| 05/03/2001 | CA2387229A1 Biodegradable microparticles with novel erythropoietin stimulating protein |
| 05/03/2001 | CA2387209A1 Active material within hydrogel microbeads |
| 05/03/2001 | CA2386887A1 Encapsulated active material immobilized in hydrogel microbeads |
| 05/03/2001 | CA2385929A1 Use of gdnf for treating corneal defects |
| 05/02/2001 | EP1096008A2 Human G protein-coupled receptor, PFI-014 |
| 05/02/2001 | EP1095659A1 Oil-in-water emulsions stabilised by cellulose ethers as carriers for homeopathic and plant drugs |
| 05/02/2001 | EP1095651A2 Multipor food protection |
| 05/02/2001 | EP1095274A1 Trifunctional reagent for conjugation to a biomolecule |
| 05/02/2001 | EP1095134A1 Method to prepare c-terminal modified peptides |
| 05/02/2001 | EP1094889A1 Flowable preparations of the water-in-oil emulsion type having an increased water content |
| 05/02/2001 | EP1094888A1 Flowable preparations of the water-in-oil emulsion type having an increased water content |
| 05/02/2001 | EP1094843A1 Targeted site specific drug delivery compositions and method of use |
| 05/02/2001 | EP1094841A1 Pharmaceutical levothyroxine preparation |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP1094818A1 Use of tricyclic antidepressants for local analgesia |
| 05/02/2001 | EP1094802A1 Pharmaceutical composition for injection based on paracetamol |
| 05/02/2001 | EP1094801A2 Poly(diallylamine)-based bile acid sequestrants |
| 05/02/2001 | EP1094797A1 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
| 05/02/2001 | EP1094796A1 Topical plaster with non-steroidal antirheumatic agents with an acid group |
| 05/02/2001 | EP1094795A1 Therapeutic system with addition of nacreous pigments |
| 05/02/2001 | EP1094793A1 Composition containing glycerol trinitrate, method for producing said composition and use of the same |
| 05/02/2001 | EP1094790A1 Sustained release pharmaceutical preparation |
| 05/02/2001 | EP1094781A1 Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
| 05/02/2001 | EP1094721A1 Coloration with pearly luster pigments in the food and pharmaceutical sectors |
| 05/02/2001 | EP0966427B1 Preparation of acid amides and metallisation of compounds |
| 05/02/2001 | CN2428209Y Device for making medical oxygen-contained injection |
| 05/02/2001 | CN1293577A Iron-dextran compound for use as component in therapeutical composition for prophylaxis or treatment of iron-deficiency, process for producing said iron-dextran compound and use of said compound for p |
| 05/02/2001 | CN1293571A Extended release tiagabine formulations with reduced side-effects |
| 05/02/2001 | CN1293570A Pharmaceutical formulations for taxanes |
| 05/02/2001 | CN1293568A Lipophilic microparticles containing protein drug or antigen and formulation comprising same |
| 05/02/2001 | CN1293553A Liquid polymeric compositions for controlled release of bioactive substances |
| 05/02/2001 | CN1293215A Polymer containing siloxane, its preparation method and use |
| 05/02/2001 | CN1065141C Pharmacuetical preparation for administration from nasal mucosa |
| 05/02/2001 | CN1065110C Colloidally disperson agent of active compount |
| 05/01/2001 | US6225445 Fatty acid derivatives of sulfhydryl-containing compounds (for example, sulfhydryl-containing peptides or proteins) comprising fatty acid-conjugated products with a disulfide linkage |
| 05/01/2001 | US6225444 Bind calcium and which are useful in treating stroke and other neurodegenerative diseases |
| 05/01/2001 | US6225356 Cromolyn sodium containing composition and method of treatment for vilvar vestibulitis interstitial cystitis vukvar vaginitis and vaginitis dynea |
| 05/01/2001 | US6225343 Compositions and methods comprising morphine gluconate |
| 05/01/2001 | US6225304 Dry solid mixture of an amoxicillin and a hydroxy-polycarboxylic acid |
| 05/01/2001 | US6225289 Methods and compositions for preserving adenoviral vectors |
| 05/01/2001 | US6224912 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 05/01/2001 | US6224910 Method for the preparation of an enteric coated high drug load pharmaceutical composition |
| 05/01/2001 | US6224909 Fast decomposing pellets |
| 05/01/2001 | US6224904 Compressed form |
| 05/01/2001 | US6224899 Adhesive cooling composition and process for its preparation |
| 05/01/2001 | US6224893 Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
| 05/01/2001 | US6224891 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions |
| 05/01/2001 | US6224887 Antifungal nail lacquer and method using same |
| 05/01/2001 | US6224883 Supplying to tumor, cancer |
| 05/01/2001 | US6224862 Mixture of prothrombinase and protein; anticoagulant |
| 05/01/2001 | US6224857 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics |
| 05/01/2001 | US6224853 Aqueous compositions comprising a lipid and a lanolin-derived surfactant, and their use |